# Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection

> **NCT07228702** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Vancouver Coastal Health** · enrollment: 1 (estimated)

## Conditions studied

- Non-Tuberculous Mycobacterial (NTM) Pneumonia
- Mycobacterium Abscessus Infection

## Interventions

- **BIOLOGICAL:** Mycobacteriophage Muddy_HRMN0052
- **DRUG:** Amikacin Injection
- **DRUG:** Clofazimine
- **DRUG:** Bedaquiline (B)
- **DRUG:** Linezolid (LZD)
- **DRUG:** Sulfamethoxazole/Trimethoprim

## Key facts

- **NCT ID:** NCT07228702
- **Lead sponsor:** Vancouver Coastal Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-11
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07228702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07228702, "Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07228702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*